https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/accounts-payable https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/accrued-rent-current https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/accumulated-depreciation https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/additional-paid-in-capital https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cash-uninsured-amount https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/common-stock-value https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cost-of-revenue https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/current-assets https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/current-liabilities https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/form-d-stocks https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/gross-profit https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/income-taxes-paid https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/inventory https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/inventory-adjustments https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/inventory-gross https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/inventory-write-down https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/net-change-in-cash https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/net-income https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-expenses https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/public-float https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/retained-earnings https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/revenue https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/security-deposit https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/sga-expense https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/shares-authorized https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/shares-issued https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/shares-repurchased-value https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/total-assets https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/taxus-pharmaceuticals-holdings-inc/weighted-average-number-of-share-outstanding-basic-and-diluted